NGS-Based RNA-Sequencing Market

NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024

Report Code: BT 5297 Sep, 2019, by marketsandmarkets.com

[156 Pages Report] The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.

NGS-based RNA-seq Market

RNA sequencing platforms & consumables segment accounted for the largest share of the NGS-based RNA-sequencing market, by product & service, in 2018

Based on products & service, the market is segmented into sample preparation, RNA sequencing platforms & consumables, RNA sequencing services, and data analysis, storage & management. In 2018, the RNA sequencing platforms & consumables segment accounted for the largest share of the NGS based RNA sequencing market. This can be attributed to continuous technological advancements witnessed in the market and the increasing availability of innovative & cost-effective sequencing platforms.

Sequencing by synthesis segment accounted for the largest share of the NGS-based RNA-sequencing market, by technology, in 2018

Based on technology, the NGS-based RNA-sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing. Of all these, the sequencing by synthesis segment accounted for the largest share of this market in 2018. The dominant market position of this segment is attributed mainly to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq and MiSeq series, NextSeq, and HiSeq X Ten).

NGS-based RNA-seq Market

North America will dominate the NGS-based RNA-sequencing market during the forecast period

Based on the region, the market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the NGS-based RNA-sequencing market. This can primarily be attributed to the government support through funds for genomics research, advancements in RNA-Seq products, growing prevalence of target diseases, growing research on cancer and inherited rare diseases, and the strong presence of key players such as Illumina (US), Thermo Fisher (US), and Agilent Technologies (US).

Key Market Players

Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. (Switzerland) among others are the major players operating in the NGS-based RNA-sequencing market.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017–2024

Base Year Considered

2018

Forecast Period

2019–2024

Currency Used

Value (USD Million)

Segments Covered

Product & Service, Technology, Application, End User, and Region

Geographies Covered

North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa

Companies Covered

15 major players, including Illumina (US), Thermo Fischer Scientific (US), and Oxford Nanopore Technologies (UK), among others.

In this report, the global NGS-based RNA-sequencing market has been segmented based on product & service, technology, application, end user, and region.

By Product & Service

  • Sample Preparation Products
  • Sequencing Platforms & Consumables
  • Sequencing Services
  • Data Analysis, Storage, & Management

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing

By Application

  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling & Transcriptome Epigenetics

By End User

  • Research & Academia
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In May 2019, BGI (China) and GenomiQa (Australia) signed a services agreement for whole-genome sequencing on BGI’s DNBseqTM sequencing technology platform. Under this agreement, genomiQa will utilize BGI’s ISO15189 accredited laboratory sequencing facilities.
  • In November 2018, Illumina (US) acquired Pacific Biosciences (US), one of the leading provider of sequencing systems. This helped Illumina strengthen its sequencing product portfolio.
  • In June 2017, Agilent Technologies (US) and Agendia (US) entered into an agreement to expand their relationship to include the development of Agendia’s RNA-Seq kit version into Agilent’s current product portfolio.

Key Questions Addressed in This Report

  • What are the various types of RNA platforms/sequencers, consumables, sample preparation kits, and services offered by the top market players for NGS-based RNA-sequencing in established & emerging regions?
  • Who are the major players offering NGS-based RNA-sequencers for specific technologies such as sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing in major geographies?
  • What revenue impact will platforms and consumables have in the market during the forecast period?
  • What is the adoption pattern for platforms and consumables and sequencing services across the globe?
  • Which regions are likely to show the highest revenue generation during the forecast period?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency Used for the Study
    1.5 Market Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Estimation Methodology
           2.2.1 Product-Based Market Estimation
           2.2.2 Application-Based Market Estimation
           2.2.3 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 NGS-Based RNA-Sequencing: Market Overview
    4.2 NGS-Based RNA-Sequencing Market, By Product & Service, 2019 vs. 2024 (USD Million)
    4.3 NGS-Based RNA-Sequencing Market Share, By Technology, 2019 vs. 2024
    4.4 NGS-Based RNA-Sequencing Market, By Application, 2019 vs. 2024 (USD Million)
    4.5 NGS-Based RNA-Sequencing Market Share, By End User, 2019 vs. 2024
    4.6 Geographical Snapshot of the NGS-Based RNA-Sequencing Market

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Advantages of RNA-Seq Over Conventional Technologies
                    5.2.1.2 Increasing Number of RNA-Seq Grants
                    5.2.1.3 Growing Number of Research Activities Involving RNA-Seq
                    5.2.1.4 Rapid Growth in Precision Medicine
           5.2.2 Restraints
                    5.2.2.1 Lack of Skilled Professionals
                    5.2.2.2 Standardization Concerns of RNA-Seq in Diagnostic Testing
           5.2.3 Opportunities
                    5.2.3.1 Increasing Applications of RNA-Seq in Research
                               5.2.3.1.1 Cancer Research
                               5.2.3.1.2 Agricultural Research
           5.2.4 Challenges
                    5.2.4.1 Storage & Interpretation of Sequencing Data
                    5.2.4.2 Analysis of RNA-Seq Data for the Detection of Novel Transcripts

6 NGS-Based RNA-Sequencing Market, By Product & Service (Page No. - 41)
    6.1 Introduction
    6.2 RNA Sequencing Platforms & Consumables
           6.2.1 Increasing Availability of Platforms and Growing Consumable Usage Have Ensured the High Share of This Segment
    6.3 Sample Preparation Products
           6.3.1 Sample Preparation is the First Step of an NGS Workflow
           6.3.2 Sample Preparation Products, By Workflow
                    6.3.2.1 Library Preparation & Target Enrichment
                    6.3.2.2 Quality Control
           6.3.3 Sample Preparation Products, By Method
                    6.3.3.1 Manual Sample Preparation
                    6.3.3.2 Microfluidic Sample Preparation
                    6.3.3.3 Robotic Liquid Handling Sample Preparation
    6.4 RNA Sequencing Services
           6.4.1 Lack of Infrastructure and Expertise Among End Users has Driven Demand for Services
    6.5 Data Analysis, Storage & Management
           6.5.1 Integration of Cloud Computing and Bioinformatics, Among Other Advancements, is Contributing to Market Growth

7 NGS-Based RNA-Sequencing Market, By Technology (Page No. - 48)
    7.1 Introduction
    7.2 Sequencing By Synthesis
           7.2.1 Sbs Technology Enables the Highest Production of Base Pairs in A Short Period of Time
    7.3 Ion Semiconductor Sequencing
           7.3.1 Ion Semiconductor Sequencing Platforms Possess High-Throughput Capabilities
    7.4 Single-Molecule Real-Time Sequencing
           7.4.1 Smrt Sequencing Produces Results in A Short Time and at Lower Costs
    7.5 Nanopore Sequencing
           7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct RNA-Sequencing Capabilities

8 NGS-Based RNA-Sequencing Market, By Application (Page No. - 54)
    8.1 Introduction
    8.2 Expression Profiling Analysis
           8.2.1 Increasing Need for Improved Prognosis of Patients to Propel Market Growth
    8.3 Small RNA Sequencing
           8.3.1 Rising Need for Accurate Diagnostic Analysis to Support Market Growth
    8.4 De Novo Transcriptome Assembly
           8.4.1 Increasing Cancer Cases is Expected to Drive This Application Segment
    8.5 Variant Calling & Transcriptome Epigenetics
           8.5.1 Complicated RNA-Seq Data Analysis May Hamper the Growth of This Segment

9 NGS-Based RNA-Sequencing Market, By End User (Page No. - 60)
    9.1 Introduction
    9.2 Research & Academia
           9.2.1 Increasing Number of Collaborations Between NGS Market Players and Academic & Research Institutes to Propel Market Growth
    9.3 Hospitals & Clinics
           9.3.1 Increasing Adoption of NGS Systems in Hospitals & Clinics to Drive Market Growth
    9.4 Pharmaceutical & Biotechnology Companies
           9.4.1 Consolidation Between Biotech & Pharma Companies and NGS Market Players to Propel Market Growth
    9.5 Other End Users

10 NGS-Based RNA-Sequencing Market, By Region (Page No. - 67)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 Favorable Funding Scenario and Growing R&D Activity in the US are Driving Market Growth
             10.2.2 Canada
                        10.2.2.1 Government Initiatives for Genome Research Will Boost the Adoption of NGS Sequencing Technology
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Germany Dominates the NGS-Based RNA-Sequencing Market in Europe
             10.3.2 UK
                        10.3.2.1 Strong Presence of NGS Organizations and Supportive Initiatives Will Drive Market Growth in the UK
             10.3.3 France
                        10.3.3.1 Growing Awareness on Applications of High-Throughput Sequencing in Genetic Characterization Will Support Market Growth
             10.3.4 RoE
     10.4 Asia Pacific
             10.4.1 China
                        10.4.1.1 Strong Base of Established Players and Favorable Government Initiatives Account for China’s Large Market Share
             10.4.2 Japan
                        10.4.2.1 Growing Awareness and Rising Incidence of Genetic Disorders are Driving Demand for NGS-Based RNA-Seq in Japan
             10.4.3 India
                        10.4.3.1 Rising Awareness and Player Interest in India Will Drive Market Growth
             10.4.4 RoAPAC
     10.5 Latin America
             10.5.1 Brazil
                        10.5.1.1 High Hiv Prevalence in Brazil has Driven Demand for NGS in Research
             10.5.2 Mexico
                        10.5.2.1 Economic Growth and Support for Infrastructural Development Will Drive Market Growth in Mexico
             10.5.3 RoLA
     10.6 Middle East & Africa
             10.6.1 Lack of Infrastructure has Stifled Market Growth in the MEA

11 Competitive Landscape (Page No. - 101)
     11.1 Introduction
     11.2 Competitive Leadership Mapping
             11.2.1 Terminology/Nomenclature
                        11.2.1.1 Visionary Leaders
                        11.2.1.2 Innovators
                        11.2.1.3 Dynamic Differentiators
                        11.2.1.4 Emerging Companies
     11.3 Competitive Scenario (2015-2019)
     11.4 NGS-Based RNA-Sequencing Market Ranking, By Top Three Market Players (2018)

12 Company Profiles (Page No. - 109)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     12.1 Agilent Technologies
     12.2 BGI Group
     12.3 Eurofins Scientific
     12.4 GENEWIZ (Part of Brooks Automation)
     12.5 Hamilton Company
     12.6 Illumina
     12.7 Nugen Technologies (Part of Tecan Trading AG)
     12.8 Oxford Nanopore Technologies
     12.9 Perkinelmer
     12.10 Psomagen
     12.11 QIAGEN
     12.12 F. Hoffmann-La Roche AG
     12.13 Takara Bio
     12.14 Thermo Fisher Scientific
     12.15 Zymo Research
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies. 

13 Appendix (Page No. - 148)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (87 Tables)

Table 1 NGS-Based RNA-Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 2 RNA Sequencing Platforms & Consumables Market, By Region, 2017–2024 (USD Million)
Table 3 Sample Preparation Products Market, By Region, 2017–2024 (USD Million)
Table 4 RNA Sequencing Services Market, By Region, 2017–2024 (USD Million)
Table 5 Data Analysis, Storage & Management Market, By Region, 2017–2024 (USD Million)
Table 6 NGS-Based RNA-Sequencing Market, By Technology, 2017–2024 (USD Million)
Table 7 Sequencing By Synthesis Market, By Region, 2017–2024 (USD Million)
Table 8 Ion Semiconductor Sequencing Market, By Region, 2017–2024 (USD Million)
Table 9 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2024 (USD Million)
Table 10 Nanopore Sequencing Market, By Region, 2017–2024 (USD Million)
Table 11 NGS-Based RNA-Sequencing Market, By Application, 2017–2024 (USD Million)
Table 12 Expression Profiling Analysis Market, By Region, 2017–2024 (USD Million)
Table 13 Small RNA Sequencing Market, By Region, 2017–2024 (USD Million)
Table 14 De Novo Transcriptome Assembly Market, By Region, 2017–2024 (USD Million)
Table 15 Variant Calling & Transcriptome Epigenetics Market, By Region, 2017–2024 (USD Million)
Table 16 NGS-Based RNA-Sequencing Market, By End User, 2017–2024 (USD Million)
Table 17 NGS-Based RNA-Sequencing Market for Research & Academia, By Region, 2017–2024 (USD Million)
Table 18 NGS-Based RNA-Sequencing Market for Hospitals & Clinics, By Region, 2017–2024 (USD Million)
Table 19 NGS-Based RNA-Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2024 (USD Million)
Table 20 NGS-Based RNA-Sequencing Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 21 NGS-Based RNA-Seq Market, By Region, 2017-2024 (USD Million)
Table 22 North America: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 23 North America: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 24 North America: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 25 North America: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 26 North America: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 27 US: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 28 US: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 29 US: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 30 Canada: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 31 Canada: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 32 Canada: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 33 Europe: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 34 Europe: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 35 Europe: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 36 Europe: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 37 Europe: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 38 Germany: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 39 Germany: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 40 Germany: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 41 UK: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 42 UK: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 43 UK: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 44 France: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 45 France: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 46 France: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 47 RoE: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 48 RoE: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 49 RoE: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 50 Asia Pacific: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 51 Asia Pacific: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 52 Asia Pacific: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 53 Asia Pacific: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 54 Asia Pacific: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 55 China: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 56 China: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 57 China: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 58 Japan: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 59 Japan: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 60 Japan: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 61 India: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 62 India: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 63 India: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 64 RoAPAC: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 65 RoAPAC: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 66 RoAPAC: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 67 Latin America: NGS-Based RNA-Seq Market, By Country, 2017–2024 (USD Million)
Table 68 Latin America: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 69 Latin America: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 70 Latin America: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 71 Latin America: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 72 Brazil: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 73 Brazil: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 74 Brazil: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 75 Mexico: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 76 Mexico: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 77 Mexico: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 78 RoLA: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 79 RoLA: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 80 RoLA: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 81 MEA: NGS-Based RNA-Seq Market, By Product & Service, 2017–2024 (USD Million)
Table 82 MEA: NGS-Based RNA-Seq Market, By Technology, 2017–2024 (USD Million)
Table 83 MEA: NGS-Based RNA-Seq Market, By Application, 2017–2024 (USD Million)
Table 84 MEA: NGS-Based RNA-Seq Market, By End User, 2017–2024 (USD Million)
Table 85 New Product Launches
Table 86 Acquisitions
Table 87 Partnerships, Agreements, and Collaborations


List of Figures (38 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Product-Based Market Estimation: NGS-Based RNA-Sequencing Market
Figure 5 Application-Based Market Estimation: NGS-Based RNA-Sequencing Market
Figure 6 Data Triangulation
Figure 7 Assumptions of the Research Study
Figure 8 NGS-Based RNA-Sequencing Market, By Product & Service, 2019 vs. 2024 (USD Million)
Figure 9 NGS-Based RNA-Sequencing Market, By Technology, 2019 vs. 2024 (USD Million)
Figure 10 NGS-Based RNA-Sequencing Market Share, By Application, 2019 vs. 2024
Figure 11 NGS-Based RNA-Sequencing Market, By End User, 2019 vs. 2024 (USD Million)
Figure 12 NGS-Based RNA-Sequencing Market: Geographic Growth Opportunities
Figure 13 Increasing Number of Research Activities Involving RNA-Seq & Rapid Growth in Precision Medicine to Drive Market Growth
Figure 14 RNA Sequencing Platforms & Consumables to Dominate the NGS-Based RNA-Sequencing Market During the Forecast Period
Figure 15 Sequencing By Synthesis Segment Will Continue to Dominate the NGS-Based RNA-Sequencing Market in 2024
Figure 16 Expression Profiling Analysis Segment Dominates the NGS-Based RNA-Sequencing Applications Market
Figure 17 Research & Academia are the Largest End Users of NGS-Based RNA-Sequencing
Figure 18 China is the Fastest-Growing Country in the NGS-Based RNA-Sequencing Market
Figure 19 NGS-Based RNA-Sequencing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Global Funding Activities for RNA-Seq and Microarray Projects, 2009–2016
Figure 21 Number of RNA-Seq Publications Globally, 2008–2016
Figure 22 North America: NGS-Based RNA-Seq Market Snapshot
Figure 23 Europe: NGS-Based RNA-Seq Market Snapshot
Figure 24 Asia Pacific: NGS-Based RNA-Seq Market Snapshot
Figure 25 NGS-Based RNA-Sequencing Market, Competitive Leadership Mapping, 2018 (Overall Market)
Figure 26 NGS Based RNA-Sequencing Market, Competitive Leadership Mapping, 2018 (SME/Start-Ups)
Figure 27 Key Developments in the NGS Based RNA-Sequencing Market, 2016–2019
Figure 28 Illumina Held the Leading Position in the NGS Based RNA-Sequencing Market as of 2018
Figure 29 Agilent Technologies: Company Snapshot (2018)
Figure 30 Eurofins: Company Snapshot (2018)
Figure 31 Brooks Automation, Inc.: Company Snapshot (2018)
Figure 32 Illumina: Company Snapshot (2018)
Figure 33 Tecan: Company Snapshot (2018)
Figure 34 Perkin Elmer: Company Snapshot (2018)
Figure 35 QIAGEN: Company Snapshot (2018)
Figure 36 Roche: Company Snapshot (2018)
Figure 37 Takara Bio: Company Snapshot (2017)
Figure 38 Thermo Fischer: Company Snapshot (2018)

This study involved four major activities in estimating the current size of the NGS-based RNA-sequencing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation processes were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was conducted to obtain key information about market classification and segmentation, geographical scenario, key developments undertaken by major market players, and the identification of key industry trends. The secondary sources used for this study include annual reports, press releases, and investor presentations of companies; white papers; certified publications; and articles from recognized websites, databases, and directories.

Primary Research

Extensive primary research was conducted after acquiring a preliminary understanding of the global NGS-based RNA-sequencing market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (companies providing sequencing services, cancer research laboratories, hospitals, research universities, and government laboratories, among others) and supply-side respondents (NGS platform manufacturers, NGS reagent & consumables providers and distributors, among others) across North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 30% and 70% of primary interviews were conducted with both the demand- and supply-side respondents, respectively. The primary data was collected through questionnaires, e-mails, online surveys, and telephonic interviews. A breakdown of primary respondents is provided below:

NGS-based RNA-seq Market

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

  • The key players in the global NGS based RNA-sequencing market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts to gather key insights on various market segments and sub-segments.
  • All segmental shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.
  • Major macro indicators that affect market segments and subsegments covered in this research study have been accounted for, viewed in detail, verified through primary research, and analyzed to understand their impact on market growth and revenues of various segments and sub-segments.
  • The data mentioned above was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation:

After deriving the overall NGS based RNA-sequencing market value data from the market size estimation process explained above, the total market value data was split into several segments and subsegments. Data triangulation and market breakdown methodologies were undertaken to complete the overall market engineering process and arrive at the exact statistics for all segments, wherever applicable. The data was triangulated by studying various qualitative & quantitative variables as well as by analyzing regional trends for both the demand and supply side macro indicators.

Report Objectives:

  • To define, describe, and forecast the global NGS based RNA-sequencing market based on product & service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the NGS based RNA-sequencing market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the global NGS based RNA-sequencing market
  • To analyze key growth opportunities in the NGS based RNA sequencing market for key stakeholders and provide details of the competitive landscape for key market players
  • To forecast the market value of various segments and/or subsegments with respect to six major regional segments—North America (US and Canada), Europe (Germany, UK, France, and RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America (Brazil, Mexico, and RoLA), and the Middle East & Africa
  • To profile key players in the global NGS based RNA-sequencing market and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments undertaken by major players in the global NGS based RNA-sequencing market such as product launches; agreements, partnerships, and collaborations; expansions; and mergers & acquisitions

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the NGS-based RNA-sequencing market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the NGS-based RNA-sequencing market

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
BT 5297
Published ON
Sep, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the NGS-Based RNA-Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home